Visakhapatnam, India

Siva Prasad Reddy Seerapu

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Siva Prasad Reddy Seerapu. Retrieved from https://idiyas.com/inventor/siva-prasad-reddy-seerapu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Siva Prasad Reddy Seerapu: Innovator in Pharmaceutical Patents

Introduction

Siva Prasad Reddy Seerapu is a notable inventor based in Visakhapatnam, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of polymorphic forms of drugs. His work has implications for the efficacy and stability of medications.

Latest Patents

Siva Prasad Reddy Seerapu holds a patent for "Polymorphic crystalline Forms J, K, L, M, and N of esomeprazole sodium." This innovation is crucial for enhancing the therapeutic properties of esomeprazole sodium, a medication commonly used to treat gastroesophageal reflux disease.

Career Highlights

He is currently associated with Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality. His role at the company allows him to contribute to the development of new and improved pharmaceutical products.

Collaborations

Siva Prasad Reddy Seerapu has collaborated with talented professionals such as Saurabh Shashikant Chitre and Srinivas Reddy Mamilla. These collaborations have fostered a creative environment that encourages the advancement of pharmaceutical research.

Conclusion

Siva Prasad Reddy Seerapu is a distinguished inventor whose work in polymorphic forms of esomeprazole sodium showcases his dedication to improving pharmaceutical formulations. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…